02 August 2021 4 282 Report

Hello, everyone. I am currently working on oncolytic herpesvirus 1. "To guarantee the genomic homogeneity and the purity of a virus stock, the initial inoculum has to derive from a single infectious particle isolated by a limiting dilution procedure." This is what a protocol (Herpes simplex viruses_methods and protocols, 2nd edition, Springer Protocols) told me. But its procedures made me confused (please check the attached picture for it). Furthermore, when I searched "limiting dilution", I only got protocols for isolating cells or testing titers of virus stocks.

In step 6, it said, "Identify and mark the wells containing single plaques." However, since the cells are not overlayed by methylcellulose or agarose, the released viruses can move freely in the medium. If there is a well containing a single virus at the beginning, progeny viruses produced will infect other cells and ultimately make multiple plaques. So I wonder how can wells containing single plaques exist.

I cannot find more information by myself. What's your experience with virus isolation and could you provide me with any information you have? Thank you for your time.

More Shu-Jin Li's questions See All
Similar questions and discussions